Please note, endo sessions has been updated to remove some site content from past Endocrine Society programs.
If you have any questions please contact [email protected].
Search:
Search for text in:
separate each search
term with a space
term with a space
Multiple terms:
Quick Links:
Additional Search Filters:
Access:
Availability:
| Browse by: | Sort by: |
Mild Cushing’s Syndrome: Does It Matter?
Danae Delivanis, MD, PhD
Private Practice, Patras, Greece
Available
Treatment of Bilateral Adrenal Macronodular Hyperplasia
Jerome Bertherat, MD, PhD
Hopital Cochin, Paris, France
Available
Focus on Cortisol Excess in Primary Aldosteronism
Adina Turcu, MD, MS
University of Michigan Medical School, Ann Arbor, MI
Available
Chair
Eyal Robenshtok, MD
Rabin Medical Center, Petah Tikva, Israel
Cepharanthine Blocks the Presentation of Thyroid & Islet Peptides in a Novel Humanized Autoimmune Polyglandular Syndrome Type 3 Variant (APS3v) Mouse Model
Cheuk Wun Li, PhD
Albert Einstein College of Medicine, Bronx, NY
Audience Q&A
MERAIODE: A Redifferentiation Phase II Trial With Trametinib and Dabrafenib Followed by Radioactive Iodine Administration for Metastatic Radioactive Iodine Refractory Differentiated Thyroid Cancer Patients With a BRAFV600E Mutation (NCT 03244956)
Christine Do Cao, MD
CHRU, Hôpital Claude Huriez, Lille, France
Audience Q&A
Estimabl2: Is There a Need for Radioiodine Ablation in Low Risk Differentiated Thyroid Cancer (DTC) Patients ? : Results From the French Randomized Phase III Prospective Trial on 776 Patients (NCT 01837745)
Sophie Leboulleux, MD, PhD
Gustave Roussy, Villejuif, France
Audience Q&A
Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors
Christopher Muir, MBBS, FRACP
The University of Sydney, Sydney, Australia
Audience Q&A
Available
Chair
Emilia Pinto, PhD
St. Jude Children's Research Hospital, Memphis, TN
Chair
Enzo Lalli, MD
Institut de Pharmacologie Moleculaire et Cellulaire, Valbonne, France
Welcome and Introductions
Metabolomics of Adrenocortical Carcinoma
Vasileios Chortis, MD, PhD
University of Birmingham, Birmingham, United Kingdom
Live Moderated Q&A
Histopathologic Markers of Aggressive Pheochromocytoma/Paraganglioma
Virginia LiVolsi, MD
University of Pennsylvania Hospital, Philadelphia, PA
Live Moderated Q&A
Molecular Classification for Prognosis in Adrenocortical Carcinoma
Guillaume Assié, MD, PhD
Paris Descartes University, Paris, France
Live Moderated Q&A and Session Closing
Available
Thyroid Nodules and Cancer in Pregnant Women
Angela M. Leung, MD
UCLA David Geffen School of Medicine, Los Angeles, California, USA
Available
Anaplastic Thyroid Cancer
Electron Kebebew, MD
Stanford University, Stanford, California, USA
Tim Korevaar, MD, PhD
Erasmus University Medical Center, Rotterdam, Netherlands
Available
Thyroid Cancer Tumor Panel
Michael W. Yeh, MD
UCLA, Los Angeles, California, USA
Electron Kebebew, MD
Stanford University, Stanford, California, USA
Angela M. Leung, MD
UCLA David Geffen School of Medicine, Los Angeles, California, USA
Available
Aggressive Pituitary Tumors and Carcinomas: Two Sides of the Same Coin?
Jacqueline Trouillas, MD, PhD
University of Lyon, Lyon, France
Paid users only
Slides + audio
Available
Treatment of Aggressive Pituitary Tumors and Carcinomas
Ann I McCormack, MD, PhD
St. Vincent's Hospital, Sydney, Australia
Paid users only
Slides + audio
Coming soon
Molecular Underpinnings of the Aggressive Pituitary Tumor
Gerald Raverot, MD, PhD
Hospices Civils de Lyon, Lyon Cedex 03, France
Paid users only
Slides + audio
Available
President's Announcements and Awards
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Paid users only
Slides + audio
Available
Outstanding Innovation Award Presented to John Kopchick, PhD
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Paid users only
Slides + audio
Available
New Pathways in Cellular and Systemic Lipid Metabolism
Peter J Tontonoz, MD, PhD
University of California, Los Angeles, Los Angeles, CA
Paid users only
Slides + audio
Available
Nuclear Receptor Signaling in Breast and Prostate Cancer
Myles A Brown, MD
Dana-Farber Cancer Institute, Boston, MA
Paid users only
Slides + audio
Available
Chair
Mishaela R Rubin, MD
Columbia University, New York, NY
Paid users only
Slides + audio
Available
Genetic control of Parathyroid Gland fate specification and organogenesis
Nancy R Manley, PhD
University of Georgia, Athens, GA
Paid users only
Slides + audio
Available
Genetics of Parathyroid Tumors
Rajesh V Thakker, MD
University of Oxford, Oxford, United Kingdom
Paid users only
Slides + audio
Available
Preoperative and Surgical Approaches to Parathyroid Gland Resection
Quan-Yang Duh, MD
San Francisco VA Medical Center, San Francisco, CA
Paid users only
Slides + audio
Available
Thyroid Cancer Genetics and Implications for Therapy
Nikita Pozdeyev, MD, PhD
University of Colorado, Aurora, CO
Paid users only
Slides + audio
Available
A Glimmer of Hope: Novel Combination Therapy for the Treatment of Anaplastic Thyroid Cancer
Maria E Cabanillas, MD
The University of Texas MD Anderson Cancer Center, Houston, TX
Paid users only
Slides + audio
Available
Super-Enhancer Targeting in Advanced Thyroid Cancers
Matthew D Ringel, MD
The Ohio State University, Columbus, OH
Paid users only
Slides + audio
Available
Questions and Answers
Mabel M Ryder, MD
Mayo Clinic, Rochester, MN, United States
Nikita Pozdeyev, MD, PhD
University of Colorado, Aurora, CO
Maria E Cabanillas, MD
The University of Texas MD Anderson Cancer Center, Houston, TX
Matthew D Ringel, MD
The Ohio State University, Columbus, OH
Paid users only
Unknown permission
for presentation
for presentation
Application of New Adrenal Cancer Models to Screen Therapeutics
Katja Kiseljak-Vassiliades, DO
University of Colorado, Denver, Aurora, CO
Paid users only
Slides + audio
Available
New In Vitro Models for Studying Human Adreno-Cortical Cancer (ACC)
Leo J Hofland, PHD
Erasmus Medical Center, Rotterdam, Netherlands
Paid users only
Slides + audio
Available
